Lymphoma Trial, Recruiting (NCT05270096)

Lymphoma Trial, Recruiting NCT05270096 Sponsor: Princess Maxima Center for Pediatric Oncology Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT05270096 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a blood cancer (such as leukemia or lymphoma) that has come back or has not responded to treatment
You were first diagnosed before the age of 18, and you are younger than 25 years old at the time of joining the trial
You are being treated in a children's or young adult's care setting, and there is currently no standard treatment available for your condition
Doctors expect you to live for at least 6 weeks
Your tumor has already been tested to look at its genetic or molecular makeup, and those results are available
You have had a specific type of blood cell analysis (called flow cytometry) done at an approved laboratory, and the results are available
You, and/or your parent(s) or guardian(s) if applicable, have given written permission to have your case reviewed by the trial's specialist board, in line with local laws

Who may not be able to join:

No specific exclusion criteria have been defined for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05270096

Sponsor: Princess Maxima Center for Pediatric Oncology

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

More information: https://clinicaltrials.gov/study/NCT05270096

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a blood cancer (such as leukemia or lymphoma) that has come back or has not responded to treatment
You were first diagnosed before the age of 18, and you are younger than 25 years old at the time of joining the trial
You are being treated in a children's or young adult's care setting, and there is currently no standard treatment available for your condition
Doctors expect you to live for at least 6 weeks
Your tumor has already been tested to look at its genetic or molecular makeup, and those results are available
You have had a specific type of blood cell analysis (called flow cytometry) done at an approved laboratory, and the results are available
You, and/or your parent(s) or guardian(s) if applicable, have given written permission to have your case reviewed by the trial's specialist board, in line with local laws

Who may not be able to join:

No specific exclusion criteria have been defined for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Princess Maxima Center for Pediatric Oncology

Registry

ClinicalTrials.gov

Start date

31 December 2022

Est. completion

1 July 2030

Where this trial is recruiting

🇧🇪 Belgium 🇩🇰 Denmark 🇭🇺 Hungary 🇳🇱 Netherlands 🇪🇸 Spain 🇸🇪 Sweden 🇬🇧 United Kingdom

Primary endpoints

The proportion of patients receiving therapy according to the iLTB advice after providing the treating physician with a uniform prioritization of therapy options based on the patient's actionable events.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov